A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2002
12/24/2002	US6498019 Lecithin-cholesterol acyltransferase protein
12/24/2002	US6498018 Cultures of human CNS neural stem cells
12/24/2002	US6497881 Complex comprising streptavidin-protein a fusion protein having antibody and biotin binding sites, bound antibody specific for cell surface protein, which undergoes endocytosis after binding, bound biotinylated toxin, expressed in cell
12/24/2002	US6497873 Rhabdovirus comprising heterologous fusion protein which facilitates fusion of rhabdovirus to target cell membrane, heterologous g stem polypeptide, rhabdovirus n, p and l proteins, deletion of nucleotide sequence encoding g protein
12/24/2002	US6497872 Neural transplantation using proliferated multipotent neural stem cells and their progeny
12/19/2002	WO2002101357A2 Molecular signatures of commonly fatal carcinomas
12/19/2002	WO2002101074A2 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
12/19/2002	WO2002101057A1 Gene transfer into primate embryonic stem cells using vsv-g pseudo type simian immunodeficiency virus vector
12/19/2002	WO2002101034A1 Leptin-induced gene
12/19/2002	WO2002101005A2 A g-protein coupled receptor and uses therefor
12/19/2002	WO2002100900A2 Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof
12/19/2002	WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections
12/19/2002	WO2002100441A2 Method for treatment of vascular regeneration
12/19/2002	WO2002100435A1 Compositions and methods for enhancing nucleic acid transfer into cells
12/19/2002	WO2002100408A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels
12/19/2002	WO2002100336A2 Tissue-specific endothelial membrane proteins
12/19/2002	WO2002100335A2 Methods for improving cell line activity in immunoisolation devices
12/19/2002	WO2002100328A2 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	WO2002100324A2 Compositions and methods for the repair and construction of bone and other tissue
12/19/2002	WO2002100250A2 Wit 3.0, a novel gene to control soft tissue wound healing
12/19/2002	WO2002087341A9 Novel self-inactivating (sin) lentiviral vectors
12/19/2002	WO2002082904A3 Method of treating or retarding the development of blindness
12/19/2002	WO2002082075A9 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
12/19/2002	WO2002081677A3 Improved gene expression
12/19/2002	WO2002080981A3 Polynucleotide binding complexes comprising sterols and saponins
12/19/2002	WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002066624A3 Novel human protease and polynucleotides encoding the same
12/19/2002	WO2002064780A9 Dna sequences for human tumour suppressor genes
12/19/2002	WO2002064755A3 Post-partum mammalian placenta, its use and placental stem cells therefrom
12/19/2002	WO2002058626A9 Methods and compositions for the identification and treatment of neurodegenerative disorders
12/19/2002	WO2002048353A3 Dna-sequences, which code for an apoptosis signal transduction protein
12/19/2002	WO2002033111A3 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
12/19/2002	WO2002024727A3 New inhibitors of iapp fibril formation and uses thereof
12/19/2002	WO2002022825A3 The c. albicans tec1 gene (catec1) and the coded tec1p protein
12/19/2002	WO2002012338A3 Screening method
12/19/2002	WO2001077331A9 Human trp-like calcium channel protein-2 (tlcc-2)
12/19/2002	WO2001077169A9 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
12/19/2002	WO2001072994A9 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof
12/19/2002	WO2001068859A9 Il-17 receptor like molecules and uses thereof
12/19/2002	US20020194637 Generation of genetic engineered embryonic stem cells for use in the treatment of parkinson's, huntington's, alzheimer's, diabetes, multiple sclerosis, muscular, bone and liver disorders
12/19/2002	US20020194633 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
12/19/2002	US20020194630 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
12/19/2002	US20020194629 Treatment of Staphylococcus infections
12/19/2002	US20020193849 Thermotherapy method for treatment and prevention of breast cancer and cancer in other organs
12/19/2002	US20020193580 Synthetic nucleotide sequences for use as tools in controlling genetic engineering
12/19/2002	US20020193561 P53 protein variants and therapeutic uses thereof
12/19/2002	US20020193338 Applying a biocompatible matrix containing the DNA molecule to a wound in the body, so that repair cells that migrate to the wound site infiltrate the matrix, acquire the DNA molecule, and express the gene product encoded by the DNA in vivo
12/19/2002	US20020193337 Gene therapy by secretory gland expression
12/19/2002	US20020193335 Gene therapy for neurological tissues
12/19/2002	US20020193333 For immunization for the therapy of diseases with or without combination chemotherapy
12/19/2002	US20020193332 Identifying a mammal that has or is at risk for having a bladder disorder; administering an isolated nucleic acid comprising an unmethylated CpG sequence to the mammal, to thereby modulate an immune response in the mammal
12/19/2002	US20020193331 Non-naturally occurring nucleic acid compositions, their use for the preparation of formulations useful for transfecting a nucleic acid into cells and applications
12/19/2002	US20020193328 Use of gene product of adenovirus early region 4 ORF-6 to inhibit repair of double-strand breaks in DNA
12/19/2002	US20020193327 For therapy of eye disorders including retinitis pigmentosa, Stargardt's disease, diabetic retinopathies, retinal vascularization, or retinoblastoma
12/19/2002	US20020193325 Inhibiting growth of a tumor cell by introducing to the cell an effective amount of p19ARF protein or mimetic thereof, and p53
12/19/2002	US20020193307 Antagonism of endothelin actions
12/19/2002	US20020193296 Vaccines; therapy; prophylaxis
12/19/2002	US20020193288 Methods of treating hypertension and compositions for use therein
12/19/2002	US20020192826 Recombinant AAV vector-based transduction system and use of same
12/19/2002	US20020192824 Viral vectors having chimeric envelope proteins containing the IgG-binding domain of protein A
12/19/2002	US20020192823 Expression vector for use as tool in gene therapy
12/19/2002	US20020192822 Herpes simplex virus ICP4 is an inhibitor of apoptosis
12/19/2002	US20020192821 Increased functional activity and/or expression of ABC transporters protects against the loss of dopamine neurons associated with Parkinson's disease
12/19/2002	US20020192802 Replication competent herpes virus strains
12/19/2002	US20020192800 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of thrombosis, emphysema and liver disorders
12/19/2002	US20020192785 For use in therapeutics, diagnostics, and as research tools
12/19/2002	US20020192763 Compositions and methods for the therapy and diagnosis of prostate cancer
12/19/2002	US20020192760 Nucleotide sequences coding membrane protein for use the diagnosis and treatment of asthma, parkinson's, heart defects, hypotension, urogenital disorders
12/19/2002	US20020192758 C3b/C4b complement receptor-like molecules and uses thereof
12/19/2002	US20020192737 Detecting modulators of oxidoreductases; obtain sample, incubate with modulator, detect signal, monitor adjustment in enzyme activity
12/19/2002	US20020192729 Apoptosis protein for use in the diagnosis and treatment of cell proliferative disorders
12/19/2002	US20020192710 Diagnostics, assay methods and amelioration of muscular dystrophy symptoms
12/19/2002	US20020192706 Nucleotide sequences coding polypeptides for use treatment of cell proliferation disorders
12/19/2002	US20020192695 Detection of modulator of tumor suppressor activity; obtain sample of polypeptide, incubate with modulator, monitor adjustment in polypeptide activity
12/19/2002	US20020192688 Imaging nucleic acid delivery
12/19/2002	US20020192682 Polynucleotides and polypeptides of the IFNalpha-2 gene
12/19/2002	US20020192665 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
12/19/2002	US20020192643 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
12/19/2002	US20020192274 pH sensitive liposomal drug delivery
12/19/2002	US20020192232 Methods and compositions for impairing multiplication of HIV-1
12/19/2002	US20020192220 Compositions and methods relating to colon specific genes and proteins
12/19/2002	US20020192216 Therapeutic use
12/19/2002	US20020192200 Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells
12/19/2002	US20020192199 Composition and methods for enhanced tumor cell immunity in vivo
12/19/2002	US20020192195 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment
12/19/2002	US20020192189 AAV transduction of myoblasts
12/19/2002	US20020192188 Use of recombinant adeno-associated virus vector (rAAV) for the prevention of smooth muscle cell proliferation in a vascular graft
12/19/2002	US20020192187 Gene transfer with adenoviruses having modified fiber proteins
12/19/2002	US20020192186 Gene therapy for pulmonary edema using adenovirus vectors encoding Na,K-ATPase
12/19/2002	US20020192185 Recombinant protein production in bovine adenovirus expression vector system
12/19/2002	CA2450379A1 Molecular signatures of commonly fatal carcinomas
12/19/2002	CA2450027A1 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	CA2449934A1 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	CA2449687A1 Vascular regeneration therapy
12/19/2002	CA2449649A1 A g-protein coupled receptor and uses therefor
12/19/2002	CA2449589A1 Gene transfer into primate embryonic stem cells using vsv-g pseudotyped simian immunodeficiency virus vector
12/19/2002	CA2449517A1 Tissue-specific endothelial membrane proteins
12/19/2002	CA2447763A1 Methods for improving cell line activity in immunoisolation devices

1 ... 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 ... 870